Rainer Wessel, PhD

Education/Work experience:

  • Master’s Degree in Biology from the Universities of Münster and Heidelberg with focus on molecular biology, microbiology and biochemistr
  • Master’s thesis in molecular biology at the Max-Planck-Institut for Medical Research in Heidelberg
  • PhD in Molecular-, Cell- and Microbiology and Genetics from the University of Konstanz
  • Patent consultant training at Boehringer Ingelheim

Expertise:

  • Intellectual property, business strategy and management
  • Organization, financing and management of technology ventures and clusters
  • Oncology, infectology, immunology and biosecurity
  • Research funding
  • Lobbying

Management experience:

  • 22 years of experience in R&D, intellectual property and management
  • Various roles in international R&D and intellectual property at Boehringer Ingelheim (Osaka and Ingelheim)
  • Head of IP & licensing at Qiagen
  • Chairman of the Board of Axxima Pharmaceuticals AG and Ganymed Pharmaceuticals AG
  • Manager of the Ci3 cluster
  • Member of the Board of Directors of BIO Deutschland (winner of the “Organization of the Year” Innovation Award 2014)

General:

  • English, basic Japanese
  • “Language and Experience“ scholarship from the German Academic Exchange Service in Japan (Tokyo and Osaka)
  • Member of the Development Board of the German Center for Cancer Research  and the International Strategy Board of Oncotyrol
  • Member of the Supervisory Board of the International Council for the Life Sciences (Washington)
  • Member of the International Institute for Strategic Studies (London)